Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
0.9981
-0.1619 (-13.96%)
Apr 1, 2025, 4:00 PM EDT - Market closed
APVO's stock price has decreased by -99.43% in the past year and price targets may not have had time to catch up.
Aptevo Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$296.00
Upside
+29,556.35%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $555 → $296 | Strong Buy | Maintains | $555 → $296 | +29,556.35% | Sep 23, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $112,332 → $32,560 | Buy | Maintains | $112,332 → $32,560 | +3,262,098.18% | May 13, 2022 |
| Roth Capital | Roth Capital | Strong Buy Maintains $104,192 → $81,400 | Strong Buy | Maintains | $104,192 → $81,400 | +8,155,395.44% | May 28, 2021 |
| Piper Sandler | Piper Sandler | Buy Maintains $52,096 → $112,332 | Buy | Maintains | $52,096 → $112,332 | +11,254,483.71% | Nov 11, 2020 |
| Roth Capital | Roth Capital | Strong Buy Initiates $273,504 | Strong Buy | Initiates | $273,504 | +27,402,364.68% | Apr 11, 2018 |
| Piper Sandler | Piper Sandler | Buy Initiates $159,544 | Buy | Initiates | $159,544 | +15,984,671.07% | Sep 9, 2016 |